Article
Activation of PI3K signaling in Merkel cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Mar 2012
Nardi Valentina, Song Youngchul, Santamaria-Barria Juan A, Cosper Arjola K, Lam Quynh, Faber Anthony C, Boland Genevieve M, Yeap Beow Y, Bergethon Kristin, Scialabba Vanessa L, Tsao Hensin, Settleman Jeffrey, Ryan David P, Borger Darrell R, Bhan Atul K, Hoang Mai P, Iafrate Anthony J, Cusack James C, Engelman Jeffrey A, Dias-Santagata Dora
Abstract excerpt
PURPOSE: Merkel cell carcinoma (MCC) is an aggressive cutaneous neuroendocrine tumor, often metastatic at presentation, for which current chemotherapeutic regimens are largely ineffective. As its pathogenesis is still unknown, we hypothesized that deregulation of signaling pathways commonly activated in cancer may contribute to MCC tumorigenesis and may provide insights into targeted therapy approaches for this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
